A leading South Korean company providing a total solution for PCR molecular diagnostics, announced its selection of Microsoft as a technology partner for its SG OneSystem™ business in London, UK, on January 23 to realize 'a world free from all diseases.'
Seegene will collaborate with Microsoft to help propel the...
Bionano Genomics, Inc. announced the full commercial release of the Stratys™ system, the Company’s system for high throughput optical genome mapping (OGM).
As part of an early access program, the following 10 sites have adopted a total of 11 Stratys systems:
BC Cancer - Vancouver (Vancouver, British Columbia)
Hamilton Health...
BenevolentAI, a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Dr. Joerg Moeller as Chief Executive Officer and Executive Board member with immediate effect.
Dr. Joerg Moeller, MD, PhD, brings a wealth of experience to BenevolentAI. During his career, he has led global research...
LungQ 3.0.0 builds on 10 years of clinical trials and 200+ publications to deliver advanced segmentation of pulmonary segments and subsegments
Thirona, a global company specializing in advanced analysis of thoracic CT images with artificial intelligence, announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the...
Saama announced the release of several groundbreaking features within its AI-driven platform, including generative AI (GenAI) chat and interactive review listings (IRL), creating an unparalleled, workflow-driven environment for cross-functional collaboration. For the first time, users can ask questions of their data in natural language, and instantly receive responses – eliminating...
Iktos, a company specialized in Artificial Intelligence for new drug design, announces the appointment of Avirup Bose as Chief Business Officer.
Avirup Bose holds a PhD in Chemistry from the University of Nebraska, USA, obtained in 1997. Prior to this, he received a Master of Science in Organic Chemistry from...
Akoya Biosciences, Inc.,, The Spatial Biology Company®, announced that the newly established Queensland Spatial Biology Centre (QSBC), located in Brisbane, Australia, is using the PhenoCycler-Fusion spatial biology platform as the core technology to revolutionize the way cancer and other debilitating diseases are diagnosed and treated.
The PhenoCycler-Fusion platform facilitates the understanding of the...
Vivtex Corporation, a biotech company aiming to transform the development of oral biologic therapies for major diseases, and AI Proteins, Inc., a growing biotechnology company that utilizes computational de novo protein design to create novel therapeutic miniproteins, today announced they have entered a strategic R&D collaboration to develop novel, oral...
In a pivotal stride toward advancing cancer care, Qure.ai, a leader in artificial intelligence (AI) solutions for medical imaging, and Project Data Sphere®, a nonprofit initiative of the CEO Roundtable on Cancer, have announced their partnership to augment tumor assessments using AI-enabled solutions for clinical trials and cancer care. The collaboration aims...
Tempus, a leader in artificial intelligence and precision medicine, announced the addition of a novel MRD assay, xM, to its comprehensive testing solutions. The tumor-naïve plasma based test is available for research use only to detect circulating tumor DNA (ctDNA) in the blood of patients with early stage CRC...
